Pricing

ALTIUM CAPITAL MANAGEMENT LP

0 followers ·
NEW YORK NY
13F Summary

Subscription Required

Equal-WT
WhaleScore 2.0 ?

85

S&P 500
WhaleScore ?

Subscription Required

Equal-WT
WhaleScore 1.0 ?

Altium Capital Management is based out of New York. Their last reported 13F filing for Q4 2023 included $147,309,631 in managed 13F securities and a top 10 holdings concentration of 60.34%. Altium Capital Management's largest holding is Xenon Pharmaceuticals Inc with shares held of 290,535. Whalewisdom has at least 15 13F filings, and 158 13G filings

2023-12-31

Top Buys (13F)

Name % Change
BOXX Alpha Architect 1-3 6.62%
XENE Xenon Pharmaceutical 5.02%
CPRX Catalyst Pharmaceuti 4.39%
SVRA Savara Inc 4.25%
AXSM Axsome Therapeutics 4.1%

2023-12-31

Top Sells (13F)

2023-12-31

13F Holdings Summary

2023-12-31

13F Activity

Market Value $147m, Prior: $192m
New Purchases 22 stocks
Added To 8 stocks
Sold out of 28 stocks
Reduced holdings in 10 stocks
Top 10 Holdings % 60.34%
Turnover %[1] 75.76%
Turnover Alt %[2] 45.59%
Time Held Top 20 1.7 quarters
Time Held Top 10 0.3 quarters
Time Held All 3.42 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

2023-12-31

13F Sector Allocation Over Time

2023-12-31

Analysis

Top 20 equal-weighted holdings. Performance numbers calculated through 2023-12-31

Portfolio Performance